Literature DB >> 21910631

Genetic and epigenetic networks in intellectual disabilities.

Hans van Bokhoven1.   

Abstract

Mutations in more than 450 different genes have been associated with intellectual disability (ID) and related cognitive disorders (CDs), such as autism. It is to be expected that this number will increase three to fourfold in the next years due to the rapid implementation of innovative high-throughput sequencing technology in genetics labs. Numerous functional relationships have been identified between the products of individual ID genes, and common molecular and cellular pathways onto which these networks converge are beginning to emerge. Prominent examples are genes involved in synaptic plasticity, Ras and Rho GTPase signaling, and epigenetic genes that encode modifiers of the chromatin structure. It thus seems that there might be common pathological patterns in ID, despite its bewildering genetic heterogeneity. These common pathways provide attractive opportunities for knowledge-based therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910631     DOI: 10.1146/annurev-genet-110410-132512

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  149 in total

Review 1.  Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies.

Authors:  Andres Moreno-De-Luca; David H Ledbetter; Christa L Martin
Journal:  Lancet Neurol       Date:  2012-01-18       Impact factor: 44.182

2.  Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome.

Authors:  Gijs W E Santen; Emmelien Aten; Yu Sun; Rowida Almomani; Christian Gilissen; Maartje Nielsen; Sarina G Kant; Irina N Snoeck; Els A J Peeters; Yvonne Hilhorst-Hofstee; Marja W Wessels; Nicolette S den Hollander; Claudia A L Ruivenkamp; Gert-Jan B van Ommen; Martijn H Breuning; Johan T den Dunnen; Arie van Haeringen; Marjolein Kriek
Journal:  Nat Genet       Date:  2012-03-18       Impact factor: 38.330

3.  Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.

Authors:  Tjitske Kleefstra; Jamie M Kramer; Kornelia Neveling; Marjolein H Willemsen; Tom S Koemans; Lisenka E L M Vissers; Willemijn Wissink-Lindhout; Michaela Fenckova; Willem M R van den Akker; Nael Nadif Kasri; Willy M Nillesen; Trine Prescott; Robin D Clark; Koenraad Devriendt; Jeroen van Reeuwijk; Arjan P M de Brouwer; Christian Gilissen; Huiqing Zhou; Han G Brunner; Joris A Veltman; Annette Schenck; Hans van Bokhoven
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

Review 4.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

5.  De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.

Authors:  Detelina Grozeva; Keren Carss; Olivera Spasic-Boskovic; Michael J Parker; Hayley Archer; Helen V Firth; Soo-Mi Park; Natalie Canham; Susan E Holder; Meredith Wilson; Anna Hackett; Michael Field; James A B Floyd; Matthew Hurles; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

Review 6.  Drug discovery for autism spectrum disorder: challenges and opportunities.

Authors:  Anirvan Ghosh; Aubin Michalon; Lothar Lindemann; Paulo Fontoura; Luca Santarelli
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

7.  Exome Sequencing and the Management of Neurometabolic Disorders.

Authors:  Maja Tarailo-Graovac; Casper Shyr; Colin J Ross; Gabriella A Horvath; Ramona Salvarinova; Xin C Ye; Lin-Hua Zhang; Amit P Bhavsar; Jessica J Y Lee; Britt I Drögemöller; Mena Abdelsayed; Majid Alfadhel; Linlea Armstrong; Matthias R Baumgartner; Patricie Burda; Mary B Connolly; Jessie Cameron; Michelle Demos; Tammie Dewan; Janis Dionne; A Mark Evans; Jan M Friedman; Ian Garber; Suzanne Lewis; Jiqiang Ling; Rupasri Mandal; Andre Mattman; Margaret McKinnon; Aspasia Michoulas; Daniel Metzger; Oluseye A Ogunbayo; Bojana Rakic; Jacob Rozmus; Peter Ruben; Bryan Sayson; Saikat Santra; Kirk R Schultz; Kathryn Selby; Paul Shekel; Sandra Sirrs; Cristina Skrypnyk; Andrea Superti-Furga; Stuart E Turvey; Margot I Van Allen; David Wishart; Jiang Wu; John Wu; Dimitrios Zafeiriou; Leo Kluijtmans; Ron A Wevers; Patrice Eydoux; Anna M Lehman; Hilary Vallance; Sylvia Stockler-Ipsiroglu; Graham Sinclair; Wyeth W Wasserman; Clara D van Karnebeek
Journal:  N Engl J Med       Date:  2016-05-25       Impact factor: 91.245

8.  MED23-associated intellectual disability in a non-consanguineous family.

Authors:  Aditi Trehan; Jacqueline M Brady; Valerie Maduro; William P Bone; Yan Huang; Gretchen A Golas; Megan S Kane; Paul R Lee; Audrey Thurm; Andrea L Gropman; Scott M Paul; Gilbert Vezina; Thomas C Markello; William A Gahl; Cornelius F Boerkoel; Cynthia J Tifft
Journal:  Am J Med Genet A       Date:  2015-04-02       Impact factor: 2.802

Review 9.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

Review 10.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.